Singapore markets open in 22 minutes

Precision BioSciences, Inc. (DTIL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.7700+0.1800 (+11.32%)
At close: 04:00PM EDT
1.7701 +0.00 (+0.01%)
After hours: 05:55PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 98.86M
Enterprise value -8.68M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.93
Price/book (mrq)1.42
Enterprise value/revenue -0.08
Enterprise value/EBITDA 0.29

Trading information

Stock price history

Beta (5Y monthly) 1.61
52-week change 3-83.07%
S&P500 52-week change 3-3.35%
52-week high 314.3800
52-week low 31.4900
50-day moving average 32.7908
200-day moving average 37.2632

Share statistics

Avg vol (3-month) 3719.71k
Avg vol (10-day) 3828.17k
Shares outstanding 562.18M
Implied shares outstanding 6N/A
Float 851.01M
% held by insiders 110.27%
% held by institutions 155.21%
Shares short (28 Apr 2022) 42.77M
Short ratio (28 Apr 2022) 45.02
Short % of float (28 Apr 2022) 44.87%
Short % of shares outstanding (28 Apr 2022) 44.54%
Shares short (prior month 30 Mar 2022) 42.07M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin -26.49%
Operating margin (ttm)-34.11%

Management effectiveness

Return on assets (ttm)-13.62%
Return on equity (ttm)-45.14%

Income statement

Revenue (ttm)115.53M
Revenue per share (ttm)1.97
Quarterly revenue growth (yoy)-28.30%
Gross profit (ttm)115.53M
EBITDA -30.42M
Net income avi to common (ttm)-30.6M
Diluted EPS (ttm)-0.5210
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)143.66M
Total cash per share (mrq)2.35
Total debt (mrq)9.11M
Total debt/equity (mrq)10.00
Current ratio (mrq)4.50
Book value per share (mrq)1.50

Cash flow statement

Operating cash flow (ttm)-10.85M
Levered free cash flow (ttm)-12.86M